As the Union Finance Minister Nirmala Stiharaman is all set to present the Union Budget 2025-26 on February 01, GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 may see a negative opening. Here’s a look at the key stocks to watch in trade.
Stocks in Focus: GIFT Nifty was trading 97 points or 0.41% lower at 23,533 indicating a negative start for domestic indices NSE Nifty 50 and BSE Sensex on Saturday. Previously, on Friday, the NSE Nifty 50 closed the session 258.90 points or 1.11% higher at 23,508.40, while the BSE Sensex added 740.76 points or 0.97% to close at 77,500.57.
Stocks to watch on February 01, 2024 Nestle India
Nestlé India reported a 6.2% year-on-year increase in standalone net profit to Rs 696.1 crore for Q3 FY25, falling short of street estimates due to weak urban consumption and high inflation. Its revenue from operations came in at Rs 4,779.7 crore for the reporting quarter of FY25, compared to an estimated Rs 4,797 crore. However, revenue grew 3.8% y-o-y, up from Rs 4,600.4 crore in Q3 FY24.
Also Read Stocks To Watch: Tata Motors, GAIL, Bajaj Finserv, BoB, Sagility, L&T, Biocon, PB Fintech, Prestige Estates, Western Carriers Stocks To Watch: Religare Enterprises, NTPC, Tata Electronics, Godrej Consumer, DLF, Adani Group, JSW Steel, IndiGo Stocks To Watch: ITC Hotels, Indian Oil Corp, JSW Energy, Colgate Palmolive, Hindustan Zinc, Suzlon Energy, Bajaj Auto Stocks To Watch: Tata Motors, KPIT Tech, Maruti Suzuki, Bajaj Finance, Brigade Enterprises, Raymond, Mineral Stocks, GR Infra, Afcons Infra ONGC
ONGC reported a third-quarter profit miss on Friday, as buoyant fuel demand failed to cushion the explorer from lower crude realisations. The state-owned firm’s standalone profit fell 17% to Rs 8,240 crore rupees ($952 million) in the October-December period and came far below analysts’ average expectation of Rs 17,931 crore. Standalone earnings exclude profit from its joint ventures and operations outside the country. ONGC contributes to around 71% of domestic crude oil production.
AstraZeneca
AstraZeneca scrapped plans to invest 450 million pounds ($558.3 million) in its vaccine manufacturing plant in northern England, citing a cut in British government support. The decision to ditch the development of an existing facility in the Speke area of Liverpool comes at a time when Prime Minister Keir Starmer is pushing hard to drum up investment in Britain to generate economic growth.
» Read More
